Editas Medicine

Director, Quality Control

Cambridge, Massachusetts, United States · Director

Sponsorship not specified$215k-$235kDetected 5 days ago

Business DevelopmentGMPFDA RegulatoryCRISPRResearchAnimal StudiesLeadershipCollaborationWritingOrganizational Skills

About the role

The Quality team is seeking a highly motivated and experienced technical and organizational leader in gRNA, mRNA, and Lipid Nanoparticle (LNP) analytical methodologies and GMP testing.
The individual will also be a key contributor to the overall program CMC strategy.

Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.
We invite you to apply and join us at the forefront of innovation and be a key contributor to realizing Editas Medicine's mission of developing transformative medicines for people living with serious diseases.
Ability to develop analytical control strategies that are phase-appropriate (i.e., phase 1 vs. phase 3 requirements) and grounded in principles of risk management.

Strong technical expertise and hands-on experience with analytical test method optimization, validation, and transfers as well as CTO/CMO management are required.
Ability to apply Quality-by-Design (QbD) principles to process development strategy planning and execution is required.

$215,000 - $235,000 Pay Transparency Editas Medicine is committed to transparency and accuracy in our hiring practices.
The anticipated salary range for each position is posted within the role.
The final salary offer will be determined based on a comprehensive assessment of the candidate's qualifications, including education, training, and relevant experience.
Editas Medicine's compensation philosophy ensures fair and equitable pay practices.

Additional factors such as external market conditions, the role's criticality, and internal equity will also be considered.

At Editas Medicine, we are pioneering the possible.
Our mission and commitment is to translate the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.
At Editas Medicine, we're a team of courageous problem solvers, harnessing the power and potential of CRISPR gene editing to transform the future of medicine.

This listing is sourced directly from Editas Medicine's careers page and normalized into a canonical job model.